Company · CIK 1838716
Genenta Science S.p.A.
| CIK | 1838716 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | L6 |
| Business address | Italy |
| Listed | GNTA (Nasdaq) |
| First annual or quarterly report | 2022-05-02 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-271901 | 2023-05-12 | 2026-01-27 | 7 | |
| 333-260923 | 2021-11-09 | 2021-12-15 | 5 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-01-27 | 424B5Shelf takedown | 333-271901 | 0001493152-26-003684 |
| 2025-10-28 | 424B5Shelf takedown | 333-271901 | 0001493152-25-019853 |
| 2025-03-28 | 424B5Shelf takedown | 333-271901 | 0001641172-25-001211 |
| 2024-12-20 | 424B5Shelf takedown | 333-271901 | 0001493152-24-051048 |
| 2024-04-26 | 424B5Shelf takedown | 333-271901 | 0001493152-24-016707 |
| 2023-05-24 | EFFECTDeclared effective | 333-271901 | 9999999995-23-001524 |
| 2023-05-12 | F-3Shelf registered | 333-271901 | 0001493152-23-016736 |
| 2021-12-15 | 424B1Final prospectus | 333-261653 | 0001493152-21-031512 |
| 2021-12-15 | 424B1Final prospectus | 333-260923 | 0001493152-21-031510 |
| 2021-12-14 | EFFECTDeclared effective | 333-260923 | 9999999995-21-004680 |
| 2021-12-07 | F-1/AAmendment | 333-260923 | 0001493152-21-030643 |
| 2021-11-24 | F-1/AAmendment | 333-260923 | 0001493152-21-029876 |
| 2021-11-09 | F-1Registration filed | 333-260923 | 0001493152-21-027683 |
| 2021-03-01 | DRSDraft made public | 377-04327 | 0001493152-21-005022 |